Klinische Neurophysiologie 2005; 36(4): 161-164
DOI: 10.1055/s-2005-915311
Originalia
© Georg Thieme Verlag KG Stuttgart · New York

Transkranielle Magnetstimulation bei amyotropher Lateralsklerose

Transcranial Magnetic Stimulation in Amyotrophic Lateral SclerosisB.  Mohammadi1 , K.  Krampfl1 , J.  Bufler1
  • 1Neurologische Klinik, Medizinische Hochschule Hannover
Further Information

Publication History

Publication Date:
08 December 2005 (online)

Zusammenfassung

Die amyotrophe Lateralsklerose (ALS) ist eine progrediente neurodegenerative Erkrankung, die das erste und zweite Motoneuron betrifft. Klinisch neurophysiologische Untersuchungen stellen eine Hauptkomponente der Diagnose dar. Die transkranielle Magnetstimulation (TMS) stellt ein weit verbreitetes, sicheres und nicht invasives Verfahren zum Studium der Physiologie des ZNS dar. Darüber hinaus ist sie ein hilfreiches Diagnostikum bei der Lokalisation von Schädigungen des motorischen Nervensystems. Die Beteiligung des ersten Motoneurons ist ein obligates Kriterium für die Diagnose der ALS. Bei fehlenden klinischen Zeichen wie positivem Babinski-Zeichen oder gesteigerten Muskeleigenreflexen kann TMS als nicht invasive Untersuchungsmethode hilfsreich sein. Mithilfe der TMS können verschiedene Parameter bestimmt werden, die in der Routinediagnostik oder zur Untersuchung der Pathophysiologie der ALS-Erkrankung herangezogen werden können. In vorliegender Übersicht werden zuerst wichtige Grundbegriffe und Techniken beschrieben und dann deren Anwendung in Diagnostik und Erforschung der ALS besprochen.

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder involving motoneurons in the spinal cord, brain stem and motor cortex. Clinical neurophysiological assessments are an important component in the diagnosis of ALS. Transcranial magnetic stimulation (TMS) is a non-invasive method to evaluate the function of the upper motoneuron (UMN). UMN deficit is an essential component of the diagnosis criteria for ALS. Definite clinical evidence of UMN involvement may be elusive. Hyperreflexia may be undetectable in a wasted limb. TMS can be very useful in such cases. Different techniques of TMS will be explained in this review. We will also discuss different parameters revealed by these techniques and their meaning in the diagnosis and investigation of ALS.

Literatur

  • 1 Zeman S, Lloyd C, Meldrum B, Leigh P N. Excitatory amino acids, free radicals and the pathogenesis of motor neuron disease.  Neuropathol Appl Neurobiol. 1994;  20 219-231
  • 2 Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group.  N Engl J Med. 1994;  330 585-591
  • 3 Lacomblez L, Bensimon G, Leigh P N, Guillet P, Powe L, Durrleman S, Delumeau J C, Meininger V. A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II.  Neurology. 1996;  47 S242-250
  • 4 Eisen A, Swash M. Clinical neurophysiology of ALS.  Clin Neurophysiol. 2001;  112 2190-2201
  • 5 Ziemann U. TMS and drugs.  Clin Neurophysiol. 2004;  115 1717-1729
  • 6 Cantello R, Gianelli M, Civardi C, Mutani R. Magnetic brain stimulation: the silent period after the motor evoked potential.  Neurology. 1992;  42 1951-1959
  • 7 Mills K R. Corticomotoneuronal PSTH studies.  Muscle Nerve. 1999;  22 297-298
  • 8 Kujirai T, Caramia M D, Rothwell J C, Day B L, Thompson P D, Ferbert A, Wroe S, Asselman P, Marsden C D. Corticocortical inhibition in human motor cortex.  J Physiol. 1993;  471 501-519
  • 9 Claus D, Weis M, Jahnke U, Plewe A, Brunholzl C. Corticospinal conduction studied with magnetic double stimulation in the intact human.  J Neurol Sci. 1992;  111 180-188
  • 10 Lazzaro V Di, Oliviero A, Meglio M, Cioni B, Tamburrini G, Tonali P, Rothwell J C. Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex.  Clin Neurophysiol. 2000;  111 794-799
  • 11 Werhahn K J, Kunesch E, Noachtar S, Benecke R, Classen J. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans.  J Physiol. 1999;  517 591-597
  • 12 Magistris M R, Rösler K M, Truffert A, Myers J P. Transcranial stimulation excites virtually all motor neurons supplying the target muscle. A demonstration and a method improving the study of motor evoked potentials.  Brain. 1998;  121 437-450
  • 13 Magistris M R, Rösler K M, Truffert A, Landis T, Hess C W. A clinical study of motor evoked potentials using a triple stimulation technique.  Brain. 1999;  122 265-279
  • 14 Schriefer T N, Hess C W, Mills K R, Murray N M. Central motor conduction studies in motor neurone disease using magnetic brain stimulation.  Electroencephalogr Clin Neurophysiol. 1989;  74 431-437
  • 15 Eisen A, Shytbel W, Murphy K, Hoirch M. Cortical magnetic stimulation in amyotrophic lateral sclerosis.  Muscle Nerve. 1990;  13 146-151
  • 16 Mills K R. The natural history of central motor abnormalities in amyotrophic lateral sclerosis.  Brain. 2003;  126 2558-2566
  • 17 Attarian S, Azulay J P, Lardillier D, Verschueren A, Pouget J. Transcranial magnetic stimulation in lower motor neuron diseases.  Clin Neurophysiol. 2005;  116 35-42
  • 18 Caramia M D, Cicinelli P, Paradiso C, Mariorenzi R, Zarola F, Bernardi G, Rossini P M. Excitability changes of muscular responses to magnetic brain stimulation in patients with central motor disorders.  Electroencephalogr Clin Neurophysiol. 1991;  81 243-250
  • 19 Carvalho M de, Evangelista T, Sales-Luis M L. The corticomotor threshold is not dependent on disease duration in amyotrophic lateral sclerosis (ALS).  Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;  3 39-42
  • 20 Barker A T, Jalinous R, Freeston I L. Non-invasive magnetic stimulation of human motor cortex.  Lancet. 1985;  1 1106-1107
  • 21 Zanette G, Tamburin S, Manganotti P, Refatti N, Forgione A, Rizzuto N. Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis.  Clin Neurophysiol. 2002;  113 1688-1697
  • 22 Ziemann U, Winter M, Reimers C D, Reimers K, Tergau F, Paulus W. Impaired motor cortex inhibition in patients with amyotrophic lateral sclerosis. Evidence from paired transcranial magnetic stimulation.  Neurology. 1997;  49 1292-1298
  • 23 Chen R, Lozano A M, Ashby P. Mechanism of the silent period following transcranial magnetic stimulation. Evidence from epidural recordings.  Exp Brain Res. 1999;  128 539-542
  • 24 Wu C W, Bichot N P, Kaas J H. Converging evidence from microstimulation, architecture, and connections for multiple motor areas in the frontal and cingulate cortex of prosimian primates.  J Comp Neurol. 2000;  423 140-177
  • 25 Ziemann U. Intracortical inhibition and facilitation in the conventional paired TMS paradigm.  Electroencephalogr Clin Neurophysiol. 1999;  51, Suppl 127-136
  • 26 Salerno A, Georgesco M. Double magnetic stimulation of the motor cortex in amyotrophic lateral sclerosis.  Electroencephalogr Clin Neurophysiol. 1998;  107 133-139
  • 27 Komissarow L, Rollnik J D, Bogdanova D, Krampfl K, Khabirov F A, Kossev A, Dengler R, Bufler J. Triple stimulation technique (TST) in amyotrophic lateral sclerosis.  Clin Neurophysiol. 2004;  115 356-360
  • 28 Ellis C M, Simmons A, Jones D K. et al . Diffusion tensor MRI assesses corticospinal tract damage in ALS.  Neurology. 1999;  53 1051-1058
  • 29 Ziemann U, Ishii K, Borgheresi A. et al . Dissociation of the pathways mediating ipsilateral and contralateral motorevoked potentials in human hand and arm muscles.  J Physiol. 1999;  518, 3 895-906
  • 30 Krampfl K, Mohammadi B, Komissarow L, Dengler R, Bufler J. Mirror movements and ipsilateral motor evoked potentials in ALS.  Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;  5 154-163
  • 31 Sommer M, Tergau F, Wischer S, Reimers C D, Beuche W, Paulus W. Riluzole does not have an acute effect on motor thresholds and the intracortical excitability in amyotrophic lateral sclerosis.  J Neurol. 1999;  246 III22-26
  • 32 Stefan K, Kunesch E, Benecke R, Classen J. Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis.  Ann Neurol. 2001;  49 536-539
  • 33 Chen R, Classen J, Gerloff C, Celnik P, Wassermann E M, Hallett M, Cohen L G. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation.  Neurology. 1997;  48 1398-1403
  • 34 Berardelli A, Inghilleri M, Rothwell J C, Romeo S, Curra A, Gilio F, Modugno N, Manfredi M. Facilitation of muscle evoked responses after repetitive cortical stimulation in man.  Exp Brain Res. 1998;  122 79-84
  • 35 Lazzaro V Di, Oliviero A, Berardelli A, Mazzone P, Insola A, Pilato F, Saturno E, Dileone M, Tonali P A, Rothwell J C. Direct demonstration of the effects of repetitive transcranial magnetic stimulation on the excitability of the human motor cortex.  Exp Brain Res. 2002;  144 549-553
  • 36 Lazzaro V Di, Oliviero A, Pilato F, Saturno E, Dileone M, Meglio M, Cioni B, Papacci F, Tonali P A, Rothwell J C. Comparison of descending volleys evoked by transcranial and epidural motor cortex stimulation in a conscious patient with bulbar pain.  Clin Neurophysiol. 2004;  115 834-838
  • 37 Ziemann U, Eisen A. TMS for ALS: why and why not.  Clin Neurophysiol. 2004;  115 1237-1238

Dr. B. Mohammadi

Neurologische Klinik · Medizinische Hochschule Hannover

Carl-Neuberg-Straße 1

30625 Hannover

Email: Mohammadi.Bahram@mh-hannover.de

    >